Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
10.59
-0.51 (-4.59%)
Jun 20, 2025, 4:00 PM - Market closed
Anika Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 117.05 | 119.91 | 120.79 | 113.83 | 147.79 | 130.46 | Upgrade
|
| Revenue Growth (YoY) | 4.61% | -0.73% | 6.12% | -22.98% | 13.29% | 13.83% | Upgrade
|
| Cost of Revenue | 44.74 | 43.3 | 37.51 | 40.61 | 58.39 | 61.43 | Upgrade
|
| Gross Profit | 72.31 | 76.6 | 83.28 | 73.22 | 89.41 | 69.03 | Upgrade
|
| Selling, General & Admin | 53.39 | 55.56 | 59.93 | 51.23 | 74.1 | 56.74 | Upgrade
|
| Research & Development | 25.19 | 25.54 | 21.76 | 18.32 | 27.33 | 22.02 | Upgrade
|
| Operating Expenses | 78.58 | 81.1 | 81.69 | 69.55 | 101.42 | 78.76 | Upgrade
|
| Operating Income | -6.27 | -4.5 | 1.59 | 3.67 | -12.02 | -9.73 | Upgrade
|
| Interest Expense | - | - | - | - | -0.19 | -0.3 | Upgrade
|
| Interest & Investment Income | 2.16 | 2.34 | 2.31 | 0.65 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -4.11 | -2.16 | 3.9 | 4.32 | -12.2 | -10.03 | Upgrade
|
| Merger & Restructuring Charges | -0.61 | -0.61 | -0.75 | - | -6.47 | -4.1 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | - | -42.52 | Upgrade
|
| Asset Writedown | - | - | - | - | - | -2.44 | Upgrade
|
| Other Unusual Items | - | - | - | - | 21.1 | 30.47 | Upgrade
|
| Pretax Income | -4.72 | -2.76 | 3.16 | 4.32 | 2.43 | -28.62 | Upgrade
|
| Income Tax Expense | 6.11 | 6.06 | 6.6 | 2.12 | -1.71 | -4.64 | Upgrade
|
| Earnings From Continuing Operations | -10.83 | -8.83 | -3.44 | 2.2 | 4.13 | -23.98 | Upgrade
|
| Earnings From Discontinued Operations | -45.91 | -47.56 | -79.23 | -17.06 | - | - | Upgrade
|
| Net Income | -56.74 | -56.39 | -82.67 | -14.86 | 4.13 | -23.98 | Upgrade
|
| Net Income to Common | -56.74 | -56.39 | -82.67 | -14.86 | 4.13 | -23.98 | Upgrade
|
| Shares Outstanding (Basic) | 15 | 15 | 15 | 15 | 14 | 14 | Upgrade
|
| Shares Outstanding (Diluted) | 15 | 15 | 15 | 15 | 15 | 14 | Upgrade
|
| Shares Change (YoY) | -0.32% | 0.44% | 0.65% | -0.50% | 2.90% | -1.06% | Upgrade
|
| EPS (Basic) | -3.88 | -3.83 | -5.64 | -1.02 | 0.29 | -1.69 | Upgrade
|
| EPS (Diluted) | -3.89 | -3.83 | -5.64 | -1.02 | 0.28 | -1.69 | Upgrade
|
| Free Cash Flow | -3.35 | -2.33 | -7.22 | -3.08 | 3.25 | 11.44 | Upgrade
|
| Free Cash Flow Per Share | -0.23 | -0.16 | -0.49 | -0.21 | 0.22 | 0.80 | Upgrade
|
| Gross Margin | 61.78% | 63.89% | 68.95% | 64.33% | 60.49% | 52.91% | Upgrade
|
| Operating Margin | -5.36% | -3.75% | 1.32% | 3.22% | -8.13% | -7.46% | Upgrade
|
| Profit Margin | -48.48% | -47.02% | -68.44% | -13.05% | 2.80% | -18.38% | Upgrade
|
| Free Cash Flow Margin | -2.86% | -1.94% | -5.97% | -2.70% | 2.20% | 8.77% | Upgrade
|
| EBITDA | 1.38 | 3.63 | 15.81 | 18.16 | 2.3 | 3.74 | Upgrade
|
| EBITDA Margin | 1.18% | 3.02% | 13.09% | 15.95% | 1.56% | 2.86% | Upgrade
|
| D&A For EBITDA | 7.65 | 8.12 | 14.22 | 14.49 | 14.32 | 13.46 | Upgrade
|
| EBIT | -6.27 | -4.5 | 1.59 | 3.67 | -12.02 | -9.73 | Upgrade
|
| EBIT Margin | -5.36% | -3.75% | 1.32% | 3.22% | -8.13% | -7.46% | Upgrade
|
| Effective Tax Rate | - | - | 208.97% | 49.12% | - | - | Upgrade
|
Updated May 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.